Line 1: |
Line 1: |
| ==Primary Author(s)*== | | ==Primary Author(s)*== |
| | | |
− | Kay Weng Choy MBBS | + | Kay Weng Choy, MBBS, Monash Medical Centre |
| | | |
| __TOC__ | | __TOC__ |
Line 13: |
Line 13: |
| '''Cytoband:''' 2p23.3 | | '''Cytoband:''' 2p23.3 |
| | | |
− | '''Genomic Coordinates:''' | + | '''Genomic Coordinates:''' |
− | | |
− | Put your text here
| |
| | | |
| chr2:25,455,845-25,565,459 (GRCh37/hg19) | | chr2:25,455,845-25,565,459 (GRCh37/hg19) |
Line 25: |
Line 23: |
| Haematological malignancies e.g. | | Haematological malignancies e.g. |
| | | |
− | • Acute myeloid leukemia (AML)
| + | * Acute myeloid leukemia (AML) |
− | | + | * Myelodysplastic syndrome (MDS) |
− | • Myelodysplastic syndrome (MDS)
| + | * T-cell acute lymphoblastic leukaemia (T-ALL) |
− | | + | * Peripheral T-cell lymphoma (PTCL) |
− | • T-cell acute lymphoblastic leukaemia (T-ALL)
| + | * Myeloproliferative neoplasm (MPN) |
− | | |
− | • Peripheral T-cell lymphoma (PTCL)
| |
− | | |
− | • Myeloproliferative neoplasm (MPN)
| |
| | | |
| ==Gene Overview== | | ==Gene Overview== |
Line 64: |
Line 58: |
| {| class="wikitable sortable" | | {| class="wikitable sortable" |
| |- | | |- |
− | ! Copy Number Loss !! Copy Number Gain !! LOH !! Loss-of-Function Mutation !! Gain-of-Function Mutation !! Translocation/Fusion | + | !Copy Number Loss!!Copy Number Gain!!LOH!!Loss-of-Function Mutation!!Gain-of-Function Mutation!!Translocation/Fusion |
| |- | | |- |
− | | || || || X || || | + | | || || ||X|| || |
| |} | | |} |
| | | |
Line 133: |
Line 127: |
| 18. Toyota M, et al., (2001). Methylation profiling in acute myeloid leukemia. Blood 97(9):2823-2829, PMID 11313277. | | 18. Toyota M, et al., (2001). Methylation profiling in acute myeloid leukemia. Blood 97(9):2823-2829, PMID 11313277. |
| | | |
− | == Notes == | + | ==Notes== |
| <nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome. | | <nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome. |
| | | |
| [[Category:Cancer Genes D]] | | [[Category:Cancer Genes D]] |